Industrial Policy & Trade Monitor· 2666 actions· ✨ 90 recent

On 4 February 2026, Argentina and the United States signed the Framework Instrument for Securing of Supply in the Mining and Processing of Critical Minerals at the inaugural FORGE Critical Minerals Ministerial in Washington, DC. The instrument commits both parties to cooperation across the critical-minerals supply chain — exploration, mining, processing, refining, and value-added manufacturing — with lithium and copper as the primary strategic targets given Argentina's position as the world's fourth-largest holder of lithium reserves and an emerging copper producer in the Salta, Catamarca, and San Juan provinces. The framework is one of eleven founding bilateral instruments signed simultaneously under the FORGE (Forum on Resource Geostrategic Engagement) architecture and operationalises the Trump-Milei strategic alignment as a binding supply-chain coordination instrument. Argentina's mining-export trajectory is projected to surpass USD 20bn over the next seven years under the combined RIGI + bilateral-framework investment pull.

On 4 February 2026, Ecuador and the United States signed a bilateral critical minerals cooperation framework at the inaugural FORGE (Forum on Resource Geostrategic Engagement) Critical Minerals Ministerial in Washington DC, committing both parties to cooperation across exploration, mining, processing, refining, and value-added manufacturing of critical minerals. The instrument is the eleventh and final founding bilateral signed under the FORGE architecture, completing the cohort of 11 bilateral frameworks established at the Ministerial. Ecuador's strategic profile centres on Tier-1 porphyry copper-gold deposits (Mirador, San Carlos-Panantza, Cascabel) and emerging rare-earth-bearing carbonatites, with the framework opening access to approximately USD 10 billion in EXIM Bank and DFC financing for Ecuadorean critical-minerals projects.

On 11 March 2025 the European Commission published its proposal for a Critical Medicines Act (CMA), pillar of the broader EU pharmaceutical-resilience agenda alongside the EU Critical Raw Materials Act (filed: 2024-05-23-eu-crma-entry-into-force) and the IRA-style industrial-policy stack. The proposal targets supply security of an EU "Union List" of critical medicines (antibiotics, anti-thrombotics, oncology, cardiovascular, insulin, painkillers) by introducing four mechanisms: (1) Strategic Project status with expedited funding access for critical-medicine manufacturing or active-substance production; (2) public-procurement preferences favouring resilient supply chains and — in defined cases — EU-based production; (3) collaborative cross-Member-State procurement to address fragmented small markets; (4) state-aid framework guidance + international-partnership diversification to reduce single-country (often China-routed) API dependency.

France 2030 is a €54 billion public investment plan unveiled by President Emmanuel Macron on 12 October 2021 to fund breakthrough innovation and reindustrialisation across ten strategic priorities — small modular nuclear reactors, green hydrogen, low-carbon transport (incl. two million EVs/year), food/agritech, twenty drug therapies for cancer and chronic disease, cultural industries, space, deep-sea exploration, semiconductors and electronic components, and robotics/digital (AI/cloud). Two cross-cutting rules require 50% of investment to flow to decarbonisation and 50% to emerging innovative players. Operationalised from the 2022 budget law, the plan is coordinated by the Secrétariat général pour l'investissement (SGPI) under the Prime Minister and delivered by ANR, ADEME, Bpifrance and Caisse des Dépôts / Banque des Territoires.